Christopher R. Flowers: Congratulations to Dr. Funda Meric-Bernstam on the ESMO Targeting Anticancer Therapy Honorary Award!
Christopher R. Flowers shared a post by ESMO on LinkedIn:
“Congratulations to Dr. Funda Meric-Bernstam, Chair of the MD Anderson Department of Investigational Cancer Therapeutics on the ESMO Targeting Anticancer Therapy Honorary Award!! We were all excited the learn about this recognition for Funda’s leadership at MD Anderson and in the field.”
Quoting ESMO’s post:
“ESMO is pleased to announce that Funda Meric-Bernstam, Chair of the Department of Investigational Cancer Therapeutics – the Phase I Program and Medical Director of the Institute for Personalised Cancer Therapy (IPCG) at MD Anderson Cancer Center, was bestowed the 2024 TAT Honorary Award. She is recognised for her outstanding contributions to the field of Precision Oncology.
She will deliver her award lecture “Implementing precision oncology: From genomics to ADCs” on 26 February 2024, at the ESMOTAT24 in Paris.
Source: Christopher R. Flowers/LinkedIn and ESMO/LinkedIn